Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cellebrite DI (CLBT) Return on Capital Employed (2021 - 2025)

Cellebrite DI's Return on Capital Employed history spans 5 years, with the latest figure at 12.86% for Q4 2025.

  • Quarterly Return on Capital Employed fell 276.0% to 12.86% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 12.86% through Dec 2025, down 276.0% year-over-year, with the annual reading at 14.94% for FY2025, 306.0% down from the prior year.
  • Return on Capital Employed came in at 12.86% for Q4 2025, up from 12.43% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 17.56% in Q3 2024 to a low of 1.45% in Q3 2022.
  • The 5-year median for Return on Capital Employed is 12.86% (2025), against an average of 10.37%.
  • Year-over-year, Return on Capital Employed crashed -1231bps in 2022 and then skyrocketed 1388bps in 2023.
  • Cellebrite DI's Return on Capital Employed stood at 14.2% in 2021, then tumbled by -87bps to 1.89% in 2022, then soared by 601bps to 13.24% in 2023, then increased by 18bps to 15.62% in 2024, then dropped by -18bps to 12.86% in 2025.
  • Per Business Quant, the three most recent readings for CLBT's Return on Capital Employed are 12.86% (Q4 2025), 12.43% (Q3 2025), and 14.1% (Q2 2025).